Miacalcic Nasalspray
Miacalcic Nasalspray is an originator product from Future Health Pharma GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 59.55 to CHF 59.55 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Future Health Pharma GmbH
- ATC code
- H05BA01
- IT group
- 07.05.20 Calcitonine
- Active substances
- Calcitoninum salmonis
- Preparation type
- Originator product
- On the SL since
- 15/03/1997
- Last price change
- 01/09/2019
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Nasenspray 200 E/Dosis | Fl 1 Stk | CHF 39.67 | CHF 59.55 | 01/05/2022 | B | 7680474730028 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Osteoporoseprävention: Bei akutem Knochenschwund aufgrund plötzlicher Immobilisierung wie zum Beispiel bei Patienten mit Osteoporose-Frakturen. Vergütungsdauer maximal 3 Monate.
Morbus Paget (Osteitis deformans): Nur bei Patienten, die nicht auf alternative Behandlungen ansprechen oder bei denen alternative Behandlungen ungeeignet sind. Vergütungsdauer 3 Monate.
Bei Algodystrophie oder Sudeck-Syndrom (Neurodystrophische Störungen): Neurodystrophische Störungen aufgrund unterschiedlicher ätiologischer und prädisponierender Faktoren wie posttraumatische schmerzhafte Osteoporose, Reflexdystrophie, Schulter-Arm-Syndrom, Kausalgie und arzneimittelbedingte neurotrophische Störungen. Vergütungsdauer bis 6 Wochen.
More preparations in this group
FAQ
Is Miacalcic Nasalspray covered by Swiss health insurance?
Yes, but only under conditions. Miacalcic Nasalspray is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Miacalcic Nasalspray cost in Switzerland?
The public price is the maximum price set by the FOPH and for Miacalcic Nasalspray ranges from CHF 59.55 to CHF 59.55 per pack. The ex-factory price ranges from CHF 39.67 to CHF 39.67. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages